Wedbush Securities’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Sell
5,077
-1,486
-23% -$75.4K 0.01% 1069
2026
Q1
$350K Sell
6,563
-1,318
-17% -$77.4K 0.01% 822
2025
Q4
$490K Buy
7,881
+348
+5% +$21.5K 0.01% 688
2025
Q3
$453K Sell
7,533
-2,048
-21% -$125K 0.01% 691
2025
Q2
$600K Buy
9,581
+270
+3% +$16.2K 0.02% 567
2025
Q1
$560K Buy
9,311
+161
+2% +$10K 0.02% 572
2024
Q4
$534K Sell
9,150
-1,370
-13% -$81.4K 0.02% 580
2024
Q3
$623K Sell
10,520
-533
-5% -$30.4K 0.02% 524
2024
Q2
$619K Sell
11,053
-374
-3% -$20.9K 0.02% 548
2024
Q1
$669K Sell
11,427
-1,446
-11% -$81.7K 0.03% 530
2023
Q4
$695K Sell
12,873
-3,824
-23% -$187K 0.03% 443
2023
Q3
$810K Sell
16,697
-4,287
-20% -$228K 0.04% 359
2023
Q2
$1.19M Sell
20,984
-1,685
-7% -$92.8K 0.06% 282
2023
Q1
$1.22M Sell
22,669
-2,329
-9% -$124K 0.06% 269
2022
Q4
$1.31M Sell
24,998
-4,389
-15% -$223K 0.07% 234
2022
Q3
$1.39M Sell
29,387
-6,030
-17% -$313K 0.08% 202
2022
Q2
$1.79M Sell
35,417
-3,072
-8% -$167K 0.1% 165
2022
Q1
$2.35M Sell
38,489
-1,137
-3% -$67.8K 0.11% 149
2021
Q4
$2.61M Sell
39,626
-679
-2% -$43.5K 0.11% 148
2021
Q3
$2.53M Buy
40,305
+5,433
+16% +$347K 0.12% 137
2021
Q2
$2.1M Sell
34,872
-1,014
-3% -$58.6K 0.1% 177
2021
Q1
$1.98M Sell
35,886
-552
-2% -$30.6K 0.11% 164
2020
Q4
$1.99M Sell
36,438
-1,512
-4% -$79K 0.17% 121
2020
Q3
$1.9M Sell
37,950
-3,414
-8% -$165K 0.18% 112
2020
Q2
$1.82M Buy
41,364
+594
+1% +$25.4K 0.17% 127
2020
Q1
$1.53M Sell
40,770
-7,548
-16% -$318K 0.18% 120
2019
Q4
$2.13M Buy
48,318
+3,318
+7% +$139K 0.19% 125
2019
Q3
$1.85M Buy
45,000
+5,826
+15% +$239K 0.18% 130
2019
Q2
$1.57M Buy
39,174
+3,630
+10% +$137K 0.16% 153
2019
Q1
$1.37M Buy
35,544
+19,632
+123% +$713K 0.15% 165
2018
Q4
$530K Buy
+15,912
New +$551K 0.07% 332

Other funds holding IHI

Wedbush Securities's IHI Position: Q2 2026 in Review

Wedbush Securities reduced its iShares US Medical Devices ETF (IHI) stake by 23% in Q2 2026, selling an estimated $75.4K and leaving 5,077 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #1069.

Wedbush Securities first reported a position in IHI in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.61M in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Wedbush Securities held 5,077 shares of iShares US Medical Devices ETF worth $251K as of Q2 2026.
  • Wedbush Securities sold 1,486 iShares US Medical Devices ETF shares in Q2 2026, an estimated $75.4K.
  • iShares US Medical Devices ETF made up 0.01% of Wedbush Securities's portfolio in Q2 2026, its #1069 holding.
  • Wedbush Securities first reported a position in iShares US Medical Devices ETF in Q4 2018 and has held it in 31 quarters since.
  • Wedbush Securities's iShares US Medical Devices ETF position peaked at $2.61M in Q4 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.